{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:41:37Z","timestamp":1762018897795,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiolog\u00eda"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.rx.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T21:24:03Z","timestamp":1576617843000},"page":"213-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Seguridad del empleo de regadenos\u00f3n como f\u00e1rmaco vasodilatador en resonancia magn\u00e9tica card\u00edaca de estr\u00e9s"],"prefix":"10.1016","volume":"62","author":[{"given":"G.","family":"Bastarrika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ezponda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Garc\u00eda","family":"Baizan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Pueyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Gavira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Caballeros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rx.2019.11.002_bib0145","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rx.2019.11.002_bib0150","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rx.2019.11.002_bib0155","first-page":"991","article-title":"Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis","volume":"38","author":"Danad","year":"2017","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rx.2019.11.002_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1532-429X-15-9","article-title":"European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries","volume":"15","author":"Bruder","year":"2013","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.rx.2019.11.002_bib0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12350-011-9474-9","article-title":"Selective adenosine agonists and myocardial perfusion imaging","volume":"19","author":"Zoghbi","year":"2012","journal-title":"J Nucl Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0170","first-page":"112","article-title":"Pruebas de estr\u00e9s farmacol\u00f3gico en cardiolog\u00eda nuclear","volume":"24","author":"Beretta","year":"2009","journal-title":"Rev Urug Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0175","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2009.04.089","article-title":"Regadenoson: A New Myocardial Stress Agent","volume":"54","author":"Al Jaroudi","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0180","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12350-012-9547-4","article-title":"A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease","volume":"19","author":"Prenner","year":"2012","journal-title":"J Nucl Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0185","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/ehjci\/jet278","article-title":"Safety and tolerability of regadenoson CMR","volume":"15","author":"Nguyen","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.rx.2019.11.002_bib0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1532-429X-11-5","article-title":"Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations","volume":"11","author":"Hundley","year":"2009","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.rx.2019.11.002_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12968-015-0111-7","article-title":"Normal values for cardiovascular magnetic resonance in adults and children","volume":"17","author":"Kawel-Boehm","year":"2015","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.rx.2019.11.002_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr."},{"key":"10.1016\/j.rx.2019.11.002_bib0205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.rx.2019.11.002_bib0210","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.jacc.2005.05.097","article-title":"Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging","volume":"46","author":"Hendel","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0215","doi-asserted-by":"crossref","unstructured":"2013 American Society of Nuclear Cardiology \/MedAxiom Nuclear Survey. J Nucl Cardiol. 2014;21 Suppl 1:5-88.","DOI":"10.1007\/s12350-014-9862-z"},{"key":"10.1016\/j.rx.2019.11.002_bib0220","unstructured":"http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_-_Product_Information\/human\/001176\/WC500097100.pdf."},{"key":"10.1016\/j.rx.2019.11.002_bib0225","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1532-429X-15-85","article-title":"Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance","volume":"15","author":"Vasu","year":"2013","journal-title":"J Cardiovasc Magn Reson."},{"key":"10.1016\/j.rx.2019.11.002_bib0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0735-1097(94)90424-3","article-title":"Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry","volume":"23","author":"Cerqueira","year":"1994","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0235","first-page":"1205","article-title":"The safety of intravenous dipyridamole thallium myocardial perfusion imaging","volume":"81","author":"Ranhosky","year":"1990","journal-title":"Intravenous Dipyridamole Thallium Imaging S*tudy G*roup. Circulation."},{"key":"10.1016\/j.rx.2019.11.002_bib0240","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jmri.25032","article-title":"Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A Clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy","volume":"43","author":"Kidambi","year":"2016","journal-title":"J Magn Reson Imaging."},{"key":"10.1016\/j.rx.2019.11.002_bib0245","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2004.10.064","article-title":"Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging","volume":"45","author":"Mishra","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0250","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ahj.2011.05.014","article-title":"The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease","volume":"162","author":"Hage","year":"2011","journal-title":"Am Heart J."},{"key":"10.1016\/j.rx.2019.11.002_bib0255","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.amjcard.2009.11.042","article-title":"Blunting of the heart rate response to adenosine and regadenoson in relation to hyperglycemia and the metabolic syndrome","volume":"105","author":"Hage","year":"2010","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ahj.2009.01.011","article-title":"Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus","volume":"157","author":"Hage","year":"2009","journal-title":"Am Heart J."},{"key":"10.1016\/j.rx.2019.11.002_bib0265","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s12350-011-9429-1","article-title":"A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging","volume":"18","author":"Hage","year":"2011","journal-title":"J Nucl Cardiol."},{"key":"10.1016\/j.rx.2019.11.002_bib0270","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10554-011-9949-4","article-title":"The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study","volume":"28","author":"DiBella","year":"2012","journal-title":"Int J Cardiovasc Imaging."},{"key":"10.1016\/j.rx.2019.11.002_bib0275","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/heartjnl-2017-311658","article-title":"Role of cardiovascular magnetic resonance in the management of patients with stable coronary artery disease","volume":"104","author":"Motwani","year":"2018","journal-title":"Heart."},{"key":"10.1016\/j.rx.2019.11.002_bib0280","doi-asserted-by":"crossref","first-page":"A166","DOI":"10.1016\/S1098-3015(10)72807-2","article-title":"PCV88 Economic evaluation of the use of regadenoson in myocardial perfusion imaging: cardiovascular laboratory perspectives","volume":"13","author":"Denevich","year":"2010","journal-title":"Value Heal."}],"container-title":["Radiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833819301651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033833819301651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:45:06Z","timestamp":1758501906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033833819301651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0033833819301651"],"URL":"https:\/\/doi.org\/10.1016\/j.rx.2019.11.002","relation":{},"ISSN":["0033-8338"],"issn-type":[{"type":"print","value":"0033-8338"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seguridad del empleo de regadenos\u00f3n como f\u00e1rmaco vasodilatador en resonancia magn\u00e9tica card\u00edaca de estr\u00e9s","name":"articletitle","label":"Article Title"},{"value":"Radiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rx.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SERAM. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}